SlideShare a Scribd company logo
A Case !
A 27 years old male presents to the emergency department
with emesis, abdominal pain an altered mental status and
malaise.
He has recently been depressed.
Many empty bottles of different drugs were found in his
bedroom
There’s no further history available
Symptomatic treatment
and sent home
Toxicology but NO
overdose founded
Suspected drug toxicity from one of the mostly used over-the
counter drug … paracetamol
Acetaminophen toxicity
Presented by: Dr.Alyaa Zuhair (medical intern)
Supervised by: Dr.Mohammed Almattar
Prevalence
01 Pharmacokinetics
02
Clinical picture
03 Management
04
Prevalence
In the United States, acetaminophen toxicity has
replaced viral hepatitis as the most common
cause of acute liver failure
01
Results of a study conducted in KSA showed :
The most frequent agent in poisoning for both
groups was acetaminophen
Causes of high prevalence
over the
counter drugs
Underestimate
it’s toxicity
acetaminophen
is found in
more than one
medication they
are using
Why it’s important to
recognize paracetamol
toxicity??
If overdose is identified early enough, mortality
rates are extremely low. However, once acute
liver failure has developed, mortality is
approximately 28 percent, and a third of patients
require liver transplantation
1- Analgesic + Antipyretic
2-Excellent safety profile.
3- Pediatrics Dose:10 to 15
mgkg
Adult dose: 325 to 1000 mgdose
What’s acetaminophen?
Maximum recommended dose:
Pediatrics: 80mgkg
Adults 4 mg
1- Excessive intake (mc)
2- delay in treatment
3- Excessive CYP450 activity .
4-Decrease capacity of glucurnidation & sulfation
5- depletion of glutathione stores
Factor’s influence toxicity
Acute Alcohol ingestion Chronic Alcohol ingestion
protective by competing w
for CYP2E1 = decreasing
the amount of NAPQI
produced.
(18 or more standard alcoholic drinks [250 mg/dL])
increases the activity of CYP2E1
activity and depletes glutathione
stores and synthesis(in overdose
therapeutic dose .
Clinical
features
Histologic changes in the liver vary from
cytolysis to centrilobular necrosis. The
centrilobular region (zone III) is
preferentially involved because it is the
area of greatest concentration of CYP2E1
and therefore the site of maximal
production of NAPQI. Histologic recovery
lags behind clinical recovery and may
take up to three months.
INVESTIGATIoNS:
1- History: Time , co-ingestion, intent of use (ie, suicidal or not),
pattern of use (eg, single or repeated doses), time , co-
morbidties , risk factors.
2-serum acetaminophen
3- labs
If established toxicity, or predicted to develop toxicity based on
history and initial serum acetaminophen concentration:
electrolytes, blood urea nitrogen and creatinine, serum total
bilirubin level, prothrombin time (PT) with international
normalized ratio (INR), aspartate aminotransferase (AST),
alanine aminotransferase (ALT), amylase, and urinalysis.
- intentional ingestions or unreliable histories, toxic screening of
blood and urine for other ingested drugs should be performed
Evaluation and diagnosis
ABC
Management
Stabilization
ACTIVATED
CHARCOAL
Decontamination
N-ACETYL CYSTINE
Antidote
Give activated charcoal (AC)
50 g to all adult patients
presenting within 4 hours of
ingestion, unless
contraindicated; AC may be
useful for coingestants
beyond 4 hours
1- when APAP conce drawn
at >4hr of single acute
ingestion.
2- APAP conce in unknown
- late.
3- Known of case of
ingestion >10mcgml
4-Hepatotoxicity + Hx of
APAP.
5- Hx or suspected+ RF+
serum conce 10 mcg
What ?
When ?
How much ?
LFT  Hepatotoxicity ?
How much ?
- Unlikely from single dose less than 150 mgkg
- Likely 250 mgkg
- Unlikely from single dose less 7.5 - 10 g
- Likely 12 gkg
When ?
Liver transplantation and liver failure
Thanks for
your attention
Sources :
1.uptodate
2. Medscape

More Related Content

Similar to Paracetamol toxicity .pptx

Fulminant hepatic failure (fhf)
Fulminant hepatic failure (fhf)Fulminant hepatic failure (fhf)
Fulminant hepatic failure (fhf)
Reyad Al_Faky
 
Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Antitubercular agents in TB patients with Chronic Liver disease (CLD)Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Pratap Tiwari
 
Evaluación de resultados anormales en enzimas hepaticas en pacientes asintoma...
Evaluación de resultados anormales en enzimas hepaticas en pacientes asintoma...Evaluación de resultados anormales en enzimas hepaticas en pacientes asintoma...
Evaluación de resultados anormales en enzimas hepaticas en pacientes asintoma...
LAB IDEA
 
2014 continuum.pdf
2014 continuum.pdf2014 continuum.pdf
2014 continuum.pdf
Isaac Holanda
 
Acg guideline acute_pancreatitis_september_2013
Acg guideline acute_pancreatitis_september_2013Acg guideline acute_pancreatitis_september_2013
Acg guideline acute_pancreatitis_september_2013
iberzamz
 
Autoimmune hepatitis
Autoimmune hepatitisAutoimmune hepatitis
Autoimmune hepatitis
Ahmed Abudeif
 
Evaluación de-laboratorio-en-pancreatitis-2002
Evaluación de-laboratorio-en-pancreatitis-2002Evaluación de-laboratorio-en-pancreatitis-2002
Evaluación de-laboratorio-en-pancreatitis-2002
cesar gaytan
 
Acg guideline acute_pancreatitis_september_2013
Acg guideline acute_pancreatitis_september_2013Acg guideline acute_pancreatitis_september_2013
Acg guideline acute_pancreatitis_september_2013
cesar gaytan
 
Pancreatitis acg
Pancreatitis acgPancreatitis acg
Pancreatitis acg
Nadia Trabucco
 
Acg guideline acute_pancreatitis_september_2013 - copia
Acg guideline acute_pancreatitis_september_2013 - copiaAcg guideline acute_pancreatitis_september_2013 - copia
Acg guideline acute_pancreatitis_september_2013 - copia
hgvilla
 
Clinical Toxicology by dr.tayyaba rphppt
Clinical Toxicology by dr.tayyaba rphpptClinical Toxicology by dr.tayyaba rphppt
Clinical Toxicology by dr.tayyaba rphppt
BIANOOR123
 
Prostat cancer shamsadin
Prostat cancer shamsadinProstat cancer shamsadin
Prostat cancer shamsadin
Hawler Medical University
 
Clinical pharmacology of management of poisoning
Clinical pharmacology of management of poisoningClinical pharmacology of management of poisoning
Clinical pharmacology of management of poisoning
Ateos Foundation of Science Education and Research, Pune, M.S., India
 
Acute pancreatitis
Acute  pancreatitisAcute  pancreatitis
Acute pancreatitis
barun kumar
 
00.toxicological assessment-of-venlafaxine-acute-and-subchronic-toxicity-stud...
00.toxicological assessment-of-venlafaxine-acute-and-subchronic-toxicity-stud...00.toxicological assessment-of-venlafaxine-acute-and-subchronic-toxicity-stud...
00.toxicological assessment-of-venlafaxine-acute-and-subchronic-toxicity-stud...
Minia university, Faculty of Medicine
 
Lab Results Interpretation for Pharmacist A.Nouri
Lab Results Interpretation for Pharmacist A.NouriLab Results Interpretation for Pharmacist A.Nouri
Lab Results Interpretation for Pharmacist A.Nouri
Ahmed Nouri
 
E053026029
E053026029E053026029
E053026029
iosrphr_editor
 
Acetaminophen poisoning in pediatrics
Acetaminophen poisoning in pediatricsAcetaminophen poisoning in pediatrics
Acetaminophen poisoning in pediatrics
Mohammed Alharthi
 
MEN SYNDROMESAND GENETIC BASIS.pptx
MEN SYNDROMESAND GENETIC BASIS.pptxMEN SYNDROMESAND GENETIC BASIS.pptx
MEN SYNDROMESAND GENETIC BASIS.pptx
Sruthi Meenaxshi
 
Autoimmune Hepatitis-update-2021 powerpoint
Autoimmune Hepatitis-update-2021 powerpointAutoimmune Hepatitis-update-2021 powerpoint
Autoimmune Hepatitis-update-2021 powerpoint
ssuser4ddc5d
 

Similar to Paracetamol toxicity .pptx (20)

Fulminant hepatic failure (fhf)
Fulminant hepatic failure (fhf)Fulminant hepatic failure (fhf)
Fulminant hepatic failure (fhf)
 
Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Antitubercular agents in TB patients with Chronic Liver disease (CLD)Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Antitubercular agents in TB patients with Chronic Liver disease (CLD)
 
Evaluación de resultados anormales en enzimas hepaticas en pacientes asintoma...
Evaluación de resultados anormales en enzimas hepaticas en pacientes asintoma...Evaluación de resultados anormales en enzimas hepaticas en pacientes asintoma...
Evaluación de resultados anormales en enzimas hepaticas en pacientes asintoma...
 
2014 continuum.pdf
2014 continuum.pdf2014 continuum.pdf
2014 continuum.pdf
 
Acg guideline acute_pancreatitis_september_2013
Acg guideline acute_pancreatitis_september_2013Acg guideline acute_pancreatitis_september_2013
Acg guideline acute_pancreatitis_september_2013
 
Autoimmune hepatitis
Autoimmune hepatitisAutoimmune hepatitis
Autoimmune hepatitis
 
Evaluación de-laboratorio-en-pancreatitis-2002
Evaluación de-laboratorio-en-pancreatitis-2002Evaluación de-laboratorio-en-pancreatitis-2002
Evaluación de-laboratorio-en-pancreatitis-2002
 
Acg guideline acute_pancreatitis_september_2013
Acg guideline acute_pancreatitis_september_2013Acg guideline acute_pancreatitis_september_2013
Acg guideline acute_pancreatitis_september_2013
 
Pancreatitis acg
Pancreatitis acgPancreatitis acg
Pancreatitis acg
 
Acg guideline acute_pancreatitis_september_2013 - copia
Acg guideline acute_pancreatitis_september_2013 - copiaAcg guideline acute_pancreatitis_september_2013 - copia
Acg guideline acute_pancreatitis_september_2013 - copia
 
Clinical Toxicology by dr.tayyaba rphppt
Clinical Toxicology by dr.tayyaba rphpptClinical Toxicology by dr.tayyaba rphppt
Clinical Toxicology by dr.tayyaba rphppt
 
Prostat cancer shamsadin
Prostat cancer shamsadinProstat cancer shamsadin
Prostat cancer shamsadin
 
Clinical pharmacology of management of poisoning
Clinical pharmacology of management of poisoningClinical pharmacology of management of poisoning
Clinical pharmacology of management of poisoning
 
Acute pancreatitis
Acute  pancreatitisAcute  pancreatitis
Acute pancreatitis
 
00.toxicological assessment-of-venlafaxine-acute-and-subchronic-toxicity-stud...
00.toxicological assessment-of-venlafaxine-acute-and-subchronic-toxicity-stud...00.toxicological assessment-of-venlafaxine-acute-and-subchronic-toxicity-stud...
00.toxicological assessment-of-venlafaxine-acute-and-subchronic-toxicity-stud...
 
Lab Results Interpretation for Pharmacist A.Nouri
Lab Results Interpretation for Pharmacist A.NouriLab Results Interpretation for Pharmacist A.Nouri
Lab Results Interpretation for Pharmacist A.Nouri
 
E053026029
E053026029E053026029
E053026029
 
Acetaminophen poisoning in pediatrics
Acetaminophen poisoning in pediatricsAcetaminophen poisoning in pediatrics
Acetaminophen poisoning in pediatrics
 
MEN SYNDROMESAND GENETIC BASIS.pptx
MEN SYNDROMESAND GENETIC BASIS.pptxMEN SYNDROMESAND GENETIC BASIS.pptx
MEN SYNDROMESAND GENETIC BASIS.pptx
 
Autoimmune Hepatitis-update-2021 powerpoint
Autoimmune Hepatitis-update-2021 powerpointAutoimmune Hepatitis-update-2021 powerpoint
Autoimmune Hepatitis-update-2021 powerpoint
 

Recently uploaded

Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 

Recently uploaded (20)

Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 

Paracetamol toxicity .pptx

  • 1. A Case ! A 27 years old male presents to the emergency department with emesis, abdominal pain an altered mental status and malaise. He has recently been depressed. Many empty bottles of different drugs were found in his bedroom There’s no further history available
  • 2. Symptomatic treatment and sent home Toxicology but NO overdose founded
  • 3. Suspected drug toxicity from one of the mostly used over-the counter drug … paracetamol
  • 4. Acetaminophen toxicity Presented by: Dr.Alyaa Zuhair (medical intern) Supervised by: Dr.Mohammed Almattar
  • 6. Prevalence In the United States, acetaminophen toxicity has replaced viral hepatitis as the most common cause of acute liver failure 01 Results of a study conducted in KSA showed : The most frequent agent in poisoning for both groups was acetaminophen
  • 7.
  • 8. Causes of high prevalence over the counter drugs Underestimate it’s toxicity acetaminophen is found in more than one medication they are using
  • 9. Why it’s important to recognize paracetamol toxicity?? If overdose is identified early enough, mortality rates are extremely low. However, once acute liver failure has developed, mortality is approximately 28 percent, and a third of patients require liver transplantation
  • 10. 1- Analgesic + Antipyretic 2-Excellent safety profile. 3- Pediatrics Dose:10 to 15 mgkg Adult dose: 325 to 1000 mgdose What’s acetaminophen? Maximum recommended dose: Pediatrics: 80mgkg Adults 4 mg
  • 11.
  • 12. 1- Excessive intake (mc) 2- delay in treatment 3- Excessive CYP450 activity . 4-Decrease capacity of glucurnidation & sulfation 5- depletion of glutathione stores Factor’s influence toxicity Acute Alcohol ingestion Chronic Alcohol ingestion protective by competing w for CYP2E1 = decreasing the amount of NAPQI produced. (18 or more standard alcoholic drinks [250 mg/dL]) increases the activity of CYP2E1 activity and depletes glutathione stores and synthesis(in overdose therapeutic dose .
  • 14. Histologic changes in the liver vary from cytolysis to centrilobular necrosis. The centrilobular region (zone III) is preferentially involved because it is the area of greatest concentration of CYP2E1 and therefore the site of maximal production of NAPQI. Histologic recovery lags behind clinical recovery and may take up to three months.
  • 15. INVESTIGATIoNS: 1- History: Time , co-ingestion, intent of use (ie, suicidal or not), pattern of use (eg, single or repeated doses), time , co- morbidties , risk factors. 2-serum acetaminophen 3- labs If established toxicity, or predicted to develop toxicity based on history and initial serum acetaminophen concentration: electrolytes, blood urea nitrogen and creatinine, serum total bilirubin level, prothrombin time (PT) with international normalized ratio (INR), aspartate aminotransferase (AST), alanine aminotransferase (ALT), amylase, and urinalysis. - intentional ingestions or unreliable histories, toxic screening of blood and urine for other ingested drugs should be performed
  • 17. ABC Management Stabilization ACTIVATED CHARCOAL Decontamination N-ACETYL CYSTINE Antidote Give activated charcoal (AC) 50 g to all adult patients presenting within 4 hours of ingestion, unless contraindicated; AC may be useful for coingestants beyond 4 hours 1- when APAP conce drawn at >4hr of single acute ingestion. 2- APAP conce in unknown - late. 3- Known of case of ingestion >10mcgml 4-Hepatotoxicity + Hx of APAP. 5- Hx or suspected+ RF+ serum conce 10 mcg
  • 18. What ? When ? How much ? LFT Hepatotoxicity ?
  • 19. How much ? - Unlikely from single dose less than 150 mgkg - Likely 250 mgkg - Unlikely from single dose less 7.5 - 10 g - Likely 12 gkg
  • 21. Liver transplantation and liver failure
  • 22. Thanks for your attention Sources : 1.uptodate 2. Medscape